Synopsis:
Tamil Nadu Petro Products surged to hit its upper circuit limit after reporting an impressive net profit growth of 134 percent on a YoY basis. Additionally, EBITDA also grew strongly by 102% during the same period.
The shares of this petrochemical manufacturer and seller are in focus after reporting a robust financial performance in this quarter. In this article, we will dive more into the details of its performance.
With a market capitalisation of Rs 935 crore, the share of Tamil Nadu Petro Products Ltd reached a day’s high of Rs 103.96 per share, hitting its 5 percent upper circuit limit. Over the past five years, the stock has delivered a positive return of 175 percent.
Q1 Highlights
Tamil Nadu Petro Products’ revenue for Q1 FY26 came in at Rs 463 crore, registering a mere 0.2 percent growth from Rs 462 crore in the same quarter last year. Additionally, on a sequential basis, revenue grew by 2 percent from Rs 455 crore in Q4 FY25.
EBITDA for Q1 FY26 came in at Rs 52.45 crore, registering a 102 percent growth from Rs 26.02 crore in the same quarter last year. Additionally, on a sequential basis, EBITDA grew by 25 percent from Rs 42.04 crore in Q4 FY25.
Coming to its profitability, the company reported a net profit growth of 134 percent to Rs 35.25 crore in Q1 FY26 as compared to Rs 15.05 crore in Q1 FY25. Additionally, on a QoQ basis, it grew by 31 percent from Rs 26.88 crore.
Tamil Nādu Petroproducts Limited is in the business of producing and selling petrochemicals and industrial chemicals, both in India and internationally. Some of their main products include linear alkyl benzene (under the SUPERLAB brand), caustic soda lye, chlorine, propylene oxide, and various chlorine derivatives like hydrochloric acid and sodium hypochlorite. These products cater to a range of industries, including detergents, textiles, paper, aluminum, and water treatment.
Written by Satyajeet Mukherjee
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
